No Data
On March 11, A-share investment warning needle | Guanggang Gas: Shareholder Jinggangshan Chuanxing plans to reduce its Shareholding by no more than 2%; HengFeng Information Technology: No revenue has been formed within the scope of the "DeepSeek", "AI Asi
Shareholders of ShenZhen New Industries Biomedical Engineering, Sequoia Capital, plan to reduce their stake by no more than 1%; shareholders of Guanggang Gas, Jinggangshan Chengxing, plan to reduce their stake by no more than 2%; Beijing Jingcheng Machinery Electric stated that the sales revenue from hydrogen-related products is expected to account for about 4.22% of the company's main Business revenue from January to September 2024; Hl Corp (Shenzhen) does not have any major matters such as mergers, acquisitions, or reorganizations related to general Siasun Robot&Automation in the planning stage; Jiangsu Jingyuan Environmental Protection Co.,Ltd. stated that Cloud Computing-related Business comprises a relatively small proportion of the company's overall Business structure; HengFeng Information Technology has not generated operating income within the scope of the "DeepSeek", "AI Agents", and "Robot" Concept.
Gelonghui Announcement Selection | Jinhui Co., Ltd.: The net income for 2024 is 0.477 billion yuan, a year-on-year increase of 39.06%, and a proposed cash dividend of 2.20 yuan; HengFeng Information Technology: Has not generated revenue within the scope o
【Hot News】Beijing Jingcheng Machinery Electric (600860.SH): Sales revenue from hydrogen-related products accounts for approximately 4.22% of the company's main Business income from January to September 2024. Hl Corp (Shenzhen) (002105.SZ): There are no significant matters such as mergers and acquisitions or reorganizations involving general Siasun Robot&Automation that are in the planning stage. Jiangsu Jingyuan Environmental Protection Co.,Ltd. (688096.SH): Cloud Computing related business accounts for a relatively small proportion of the company's overall business structure. Xince Standards (300938.SZ): The joint venture 'Shenzhen Xince Standards Robot Technology Co., Ltd.' is still in the establishment process. HengFeng Information Technology (300605.SZ): Not finalized.
Express News | New Industries Biomedical Says Major Shareholder Plans to Unload up to 1% Stake in the Company Within Three Months
Does Shenzhen New Industries Biomedical Engineering (SZSE:300832) Deserve A Spot On Your Watchlist?
ShenZhen New Industries Biomedical Engineering (300832.SZ): Hepatitis B Virus Surface Antigen Detection Kit (Magnetic Microparticle Chemiluminescence Method) has received IVDR CE certification.
ShenZhen New Industries Biomedical Engineering (300832.SZ) announced that the company's product, the Hepatitis B Virus Surface Antigen Detection Kit (magnetic micro-particle...)
ShenZhen New Industries Biomedical Engineering (300832.SZ): The company's products have obtained IVDR CE certification.
On March 4, Gelonghui announced that ShenZhen New Industries (300832.SZ) has obtained the highest risk level Class D certification for its hepatitis B virus surface antigen detection kit (magnetic microparticle chemiluminescence method) from the EU notified body - TüV Süd Group. The new EU In Vitro Diagnostic Medical Devices Regulation (IVDR, EU 2017/746) replaces the previous EU In Vitro Diagnostic Medical Devices Directive (IVDD, 98/79/EC) and governs in vitro diagnostic medical instruments in the EU market. To date, the company has accumulated 170 chemiluminescent reagent products.
Shenzhen New Industries Biomedical Engineering Co., Ltd.'s (SZSE:300832) Share Price Not Quite Adding Up
